NCT06628102Recruiting
Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study
Improving Detection of Early Lung Cancer in a Diverse Population
Source: ClinicalTrials.gov · Last updated 4 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this trial is to (a) identify people at high risk of lung cancer who would benefit from LDCT screening but are currently ineligible based on current lung cancer screening criteria (b) provide the framework to manage patients with Incidental Pulmonary Nodules (IPNs) with appropriate follow-up based on accurate interpretation of the Chest CT scan that is already available and (c) develop a simple, point-of-care, minimally invasive test, focusing on the breath and circulating blood proteins, to detect lung cancer, and develop a method to differentiate between cancerous and non-cancerous nodules using a single. Participants will be asked to answer a questionnaire regarding their age, race/ethnicity, smoking history, and residential history if they have ever been told they have chronic obstructive pulmonary disease (COPD), high blood pressure, education level, medications and height and weight. Participants will then be asked to give a breath sample via the breath collection device. All this information will be collected before the breath collection. After that, participants will give 1-2 tablespoons of blood. CT scans with IPN(s) will be reviewed and run through a computer detection software to identify nodules, followed up as per current clinical guidelines.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 3600 (estimated)
- First submitted
- 10 Oct 2023
- Start date
- 4 Aug 2023
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- British Columbia Cancer Agency
- Diseases
- Lung cancer
- NCT number
- NCT06628102
What you commit to
- Study type: Interventional
- Planned participants: 3600
- From 4 Aug 2023 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- You have been diagnosed with a respiratory infection in the last 3 months
Other
- Too sick to provide a breath sample
- you have smoked in the last 24 hours
- You are pregnant
- Unwilling to consent to the study
Who the study is looking for
- Age 50-80
- Able to consent
- Chest CT positive for nodule equal to or greater than 6mm
- No additional other cancer- (outside of lung cancer for group 1)
- Must be able to abstain from smoking tobacco for 24 hours prior to the breath test.
Age in the registry: 50 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| BC Cancer Research, part of the Provincial Health Authority Coordinator of this site? Confirm its status | Vancouver | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.